Two Sigma Advisers’s Globus Medical GMED Stock Holding History

Two Sigma Advisers’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,600	Closed	-$1.19M	–	884
2025 Q4	$1.19M	Buy	13,600 +9,675	+246%	+$734K	﹤0.01%	1408
2025 Q3	$225K	Buy	+3,925	New	+$226K	﹤0.01%	2090
2024 Q4	–	Sell	-91,900	Closed	-$6.57M	–	2408
2024 Q3	$6.57M	Sell	91,900 -437,975	-83%	-$30.9M	0.02%	621
2024 Q2	$36.3M	Sell	529,875 -201,100	-28%	-$12M	0.08%	221
2024 Q1	$39.2M	Sell	730,975 -61,400	-8%	-$3.3M	0.09%	225
2023 Q4	$42.2M	Sell	792,375 -552,125	-41%	-$26.9M	0.1%	206
2023 Q3	$66.8M	Buy	1,344,500 +468,000	+53%	+$26.2M	0.17%	136
2023 Q2	$52.2M	Buy	876,500 +741,900	+551%	+$42.3M	0.13%	169
2023 Q1	$7.62M	Buy	134,600 +125,600	+1,396%	+$8.05M	0.02%	643
2022 Q4	$668K	Sell	9,000 -5,000	-36%	-$340K	﹤0.01%	1760
2022 Q3	$834K	Sell	14,000 -5,500	-28%	-$331K	﹤0.01%	1616
2022 Q2	$1.09M	Sell	19,500 -12,900	-40%	-$848K	﹤0.01%	1555
2022 Q1	$2.39M	Buy	32,400 +11,200	+53%	+$779K	0.01%	1158
2021 Q4	$1.53M	Sell	21,200 -32,700	-61%	-$2.37M	﹤0.01%	1316
2021 Q3	$4.13M	Sell	53,900 -180,600	-77%	-$14.5M	0.01%	887
2021 Q2	$18.2M	Buy	234,500 +109,800	+88%	+$7.81M	0.05%	355
2021 Q1	$7.69M	Buy	124,700 +54,100	+77%	+$3.43M	0.02%	678
2020 Q4	$4.61M	Sell	70,600 -54,400	-44%	-$3.13M	0.01%	859
2020 Q3	$6.19M	Buy	+125,000	New	+$6.45M	0.02%	694
2020 Q2	–	Sell	-15,900	Closed	-$676K	–	2529
2020 Q1	$676K	Sell	15,900 -164,100	-91%	-$8.11M	﹤0.01%	1666
2019 Q4	$10.6M	Buy	180,000 +171,700	+2,069%	+$9.32M	0.02%	581
2019 Q3	$424K	Buy	8,300 +1,100	+15%	+$52.4K	﹤0.01%	1777
2019 Q2	$305K	Sell	7,200 -73,804	-91%	-$3.2M	﹤0.01%	2006
2019 Q1	$4M	Sell	81,004 -45,500	-36%	-$2.06M	0.01%	916
2018 Q4	$5.47M	Sell	126,504 -42,106	-25%	-$2.1M	0.02%	777
2018 Q3	$9.57M	Buy	168,610 +3,400	+2%	+$179K	0.02%	596
2018 Q2	$8.34M	Buy	165,210 +51,800	+46%	+$2.7M	0.02%	641
2018 Q1	$5.65M	Buy	113,410 +24,300	+27%	+$1.14M	0.02%	800
2017 Q4	$3.66M	Sell	89,110 -1,400	-2%	-$49K	0.01%	969
2017 Q3	$2.69M	Buy	90,510 +31,600	+54%	+$965K	0.01%	1069
2017 Q2	$1.95M	Buy	58,910 +32,500	+123%	+$1.02M	0.01%	1221
2017 Q1	$782K	Sell	26,410 -97,497	-79%	-$2.66M	﹤0.01%	1699
2016 Q4	$3.07M	Buy	123,907 +47,407	+62%	+$1.08M	0.01%	962
2016 Q3	$1.73M	Buy	76,500 +64,100	+517%	+$1.51M	0.01%	1093
2016 Q2	$295K	Buy	+12,400	New	+$297K	﹤0.01%	1720
2015 Q3	–	Sell	-122,001	Closed	-$3.13M	–	1871
2015 Q2	$3.13M	Buy	122,001 +69,701	+133%	+$1.77M	0.02%	636
2015 Q1	$1.32M	Sell	52,300 -104,900	-67%	-$2.56M	0.01%	952
2014 Q4	$3.74M	Buy	+157,200	New	+$3.48M	0.03%	584

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's GMED Position: Q1 2026 in Review

Two Sigma Advisers sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 13,600 shares — an estimated $1.19M sold.

Two Sigma Advisers first reported a position in GMED in Q4 2014 and held it in 38 quarters. The position peaked at $66.8M in Q3 2023. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Two Sigma Advisers reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 13,600 Globus Medical shares in Q1 2026, an estimated $1.19M.
Two Sigma Advisers first reported a position in Globus Medical in Q4 2014 and held it in 38 quarters.
Two Sigma Advisers's Globus Medical position peaked at $66.8M in Q3 2023.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.